Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -57.97% is 10% above its 5-year average of -64.43%, near the high end of its 5-year range (-914.57%–-7.45%).
As of the fiscal period ended Tuesday, June 30, 2026. 8.31% above its 12-month average of -63.22%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -57.97%.
RETURN ON EQUITY (ROE)
-57.97%
RETURN ON EQUITY (ROE) AVG TTM
-63.22%
RETURN ON EQUITY (ROE) AVG 3Y
-59.36%
RETURN ON EQUITY (ROE) AVG 5Y
-64.43%
RETURN ON EQUITY (ROE) AVG 10Y
-102.31%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+8.31%
CURRENT VS 3Y AVG
+2.34%
CURRENT VS 5Y AVG
+10.04%
CURRENT VS 10Y AVG
+43.34%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-41.56%
median of 737 covered companies
CURRENT VS SECTOR MEDIAN
-39.48%
vs the sector median at left
Ocular Therapeutix, Inc.
Market Cap
$1.62B
Return on Equity (ROE)
-57.97%
TTM Avg
-63.22%
3Y Avg
-59.36%
5Y Avg
-64.43%
Market Cap
$1.62B
Return on Equity (ROE)
17.72%
TTM Avg
5.08%
3Y Avg
0.03%
5Y Avg
-3.88%
Market Cap
$1.62B
Return on Equity (ROE)
-6.27%
TTM Avg
-14.95%
3Y Avg
-10.20%
5Y Avg
-10.20%
Market Cap
$1.60B
Return on Equity (ROE)
3.03%
TTM Avg
0.59%
3Y Avg
-0.01%
5Y Avg
1.68%
Market Cap
$1.60B
Return on Equity (ROE)
-67.40%
TTM Avg
-53.05%
3Y Avg
2.62%
5Y Avg
2.10%
Market Cap
$1.64B
Return on Equity (ROE)
N/A
TTM Avg
-1058.20%
3Y Avg
-465.87%
5Y Avg
-348.95%
Market Cap
$1.54B
Return on Equity (ROE)
28.97%
TTM Avg
13.25%
3Y Avg
22.73%
5Y Avg
32.77%
Market Cap
$1.54B
Return on Equity (ROE)
-1462.12%
TTM Avg
-276.13%
3Y Avg
-155.50%
5Y Avg
-107.48%
Market Cap
$1.53B
Return on Equity (ROE)
-60.17%
TTM Avg
-20.40%
3Y Avg
-40.27%
5Y Avg
-36.46%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Ocular Therapeutix, Inc. (OCUL) | $1.62B | -57.97% | -63.22% | -59.36% | -64.43% |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.62B | 17.72% | 5.08% | 0.03% | -3.88% |
| Septerna Inc (SEPN)vs › | $1.62B | -6.27% | -14.95% | -10.20% | -10.20% |
| Omnicell, Inc. (OMCL)vs › | $1.60B | 3.03% | 0.59% | -0.01% | 1.68% |
| Kestra Medical Technologies, Ltd. (KMTS)vs › | $1.60B | -67.40% | -53.05% | 2.62% | 2.10% |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.64B | N/A | -1058.20% | -465.87% | -348.95% |
| Innoviva, Inc. (INVA)vs › | $1.54B | 28.97% | 13.25% | 22.73% | 32.77% |
| Syndax Pharmaceuticals, Inc. (SNDX)vs › | $1.54B | -1462.12% | -276.13% | -155.50% | -107.48% |
| Stoke Therapeutics, Inc. (STOK)vs › | $1.53B | -60.17% | -20.40% | -40.27% | -36.46% |
| uniQure N.V. (QURE)vs › | $1.53B | -77.83% | 1723.94% | 818.18% | 546.13% |
ROE
-58.0%
ROA
-44.9%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -57.97% |
| 2026-03-31 | -49.95% |
| 2025-12-31 | -40.64% |
| 2025-09-30 | -96.69% |
| 2025-06-30 | -70.85% |
| 2025-03-31 | -72.47% |
| 2024-12-31 | -61.36% |
| 2024-09-30 | -49.52% |
| 2024-06-30 | -36.63% |
| 2024-03-31 | -28.25% |
| 2023-12-31 | -88.59% |
| 2023-09-30 | -853.92% |
| 2023-03-31 | -914.57% |
| 2022-12-31 | -200.79% |
| 2022-09-30 | -128.37% |
| 2022-06-30 | -49.39% |
| 2022-03-31 | -27.84% |
| 2021-12-31 | -7.45% |
| 2021-09-30 | -101.12% |
| 2021-06-30 | -128.25% |
| 2021-03-31 | -157.06% |
| 2020-12-31 | -204.53% |
| 2019-09-30 | -688.03% |
| 2019-06-30 | -895.93% |
| 2019-03-31 | -246.95% |
| 2018-12-31 | -167.19% |
| 2018-09-30 | -122.33% |
| 2018-06-30 | -122.98% |
| 2018-03-31 | -124.28% |
| 2017-12-31 | -242.42% |
| 2017-09-30 | -175.68% |
| 2017-06-30 | -118.97% |
| 2017-03-31 | -78.06% |
| 2016-12-31 | -85.95% |
| 2016-09-30 | -68.25% |
| 2016-06-30 | -63.09% |
| 2016-03-31 | -53.65% |
| 2015-12-31 | -44.37% |
| 2015-09-30 | -37.51% |
| 2015-06-30 | -30.09% |
| 2015-03-31 | -56.11% |
| 2014-12-31 | -48.81% |
| 2014-09-30 | -36.89% |
| 2014-03-31 | -153.63% |
